Abstract
Alzheimer's disease is a neurodegenerative, irreversible condition with an increasing incidence, linked to the rising life expectancy and genetic factors. Presently, there are only four therapies approved by the Food and Drug Administration (FDA), with the current treatment being symptomatic. The pathophysiology of the disease remains uncertain, although various hypotheses are under study…